Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion

Pancreatic cancer has a high mortality rate due to metastasis. Whereas KRAS is mutated in most pancreatic cancer patients, controlling KRAS or its downstream effectors has not been succeeded clinically. ARL4C is a small G protein whose expression is induced by the Wnt and EGF–RAS pathways. In the pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Akikazu Harada, Shinji Matsumoto, Yoshiaki Yasumizu, Kensaku Shojima, Toshiyuki Akama, Hidetoshi Eguchi, Akira Kikuchi
Format: article
Language:EN
Published: eLife Sciences Publications Ltd 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/5fbe9fa95757439f8c5ea656d83a9bfd
Tags: Add Tag
No Tags, Be the first to tag this record!